OTCMKTS:PVTTF Pivotal Therapeutics (PVTTF) Stock Price, News & Analysis → Pentagon contract could send this $2 AI stock soaring (From Behind the Markets) (Ad) Free PVTTF Stock Alerts $0.0018 0.00 (0.00%) (As of 05/12/2023) Add Compare Share Share Today's Range$0.0018▼$0.001850-Day Range N/A52-Week Range$0.0018▼$0.0018VolumeN/AAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisHeadlinesStock AnalysisHeadlines Get Pivotal Therapeutics alerts: Email Address Ad Behind the MarketsPentagon contract could send this $2 AI stock soaringWhenever the Department of Defense awards a major AI contract... Early investors could see dramatic returns virtually overnight. That's how my readers were able to cash in gains like 133% in just four months on C3.ai...Get all the info here >>> About Pivotal Therapeutics Stock (OTCMKTS:PVTTF)Pivotal Therapeutics Inc., a specialty pharmaceutical company, focuses on the treatment of cardiovascular diseases and overall health. Its lead product, VASCAZEN, is a prescription only medical food formulated for clinical dietary management of cardiovascular disease in patients with documented coronary heart disease and who are deficient in blood Omega-3 fatty acids, eicosapentaenoic acid, and docosahexanenoic acid levels. The company also offers OMAZEN for the maintenance of good health through elevating Omega-3 fatty acid levels. In addition, the company develops Benefishial product line for overall health, cardiovascular health, prenatal health, toddler's health, child's health, and pet's health. Further, it is developing PVT-100 indicated for the stabilization of vulnerable plaque in patients undergoing carotid endarterectomy. Pivotal Therapeutics Inc. sells VASCAZEN in the United States and OMAZEN in Canada. The company is headquartered in Woodbridge, Canada.Read More PVTTF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart PVTTF Stock News HeadlinesApril 21, 2024 | usnews.comBiden Sees a $35 Price Cap for Insulin as a Pivotal Campaign Issue. It’s Not That Clear-CutApril 18, 2024 | msn.comThe Latest | Jury Selection Enters a Pivotal Stretch as Trump's Hush Money Trial ResumesApril 24, 2024 | Behind the Markets (Ad)Pentagon contract could send this $2 AI stock soaringWhenever the Department of Defense awards a major AI contract... Early investors could see dramatic returns virtually overnight. That's how my readers were able to cash in gains like 133% in just four months on C3.ai...April 18, 2024 | usnews.comJury Selection in Trump Hush Money Trial Faces Pivotal Stretch as Former President Returns to CourtApril 17, 2024 | usnews.comAnti-Trump Republican Larry Hogan Navigates Dangerous Political Terrain in Pivotal Senate ContestApril 14, 2024 | msn.comAmen Corner Proves Pivotal as Scottie Scheffler's Closest Pursuers Falter in Final Round of MastersApril 5, 2024 | investing.comSpotify target raised to new Street high at Pivotal ResearchApril 2, 2024 | finanznachrichten.deProtembis GmbH: Protembis Announces First Patient Enrolled in the PROTEMBO IDE Pivotal TrialApril 24, 2024 | Behind the Markets (Ad)Pentagon contract could send this $2 AI stock soaringWhenever the Department of Defense awards a major AI contract... Early investors could see dramatic returns virtually overnight. That's how my readers were able to cash in gains like 133% in just four months on C3.ai...April 2, 2024 | finance.yahoo.comProtembis Announces First Patient Enrolled in the PROTEMBO IDE Pivotal TrialMarch 28, 2024 | finance.yahoo.comJenaValve Announces Publication of ALIGN-AR Pivotal Trial Results in The LancetFebruary 28, 2024 | markets.businessinsider.comBuy Rating for Viridian Therapeutics Backed by Strong Financials and Promising Drug CandidateFebruary 24, 2024 | businessinsider.comPivotal, the flying-car company backed by Google cofounder Larry Page, lays off 10% of staffFebruary 22, 2024 | markets.businessinsider.comPivotal Delivers Four BlackFly light eVTOLs for U.S. Air Force evaluation; Contracted for Eight AircraftFebruary 22, 2024 | tmcnet.comPivotal Commware Promotes FWA Without Limits at 2024 Mobile World Congress BarcelonaFebruary 9, 2024 | msn.comDCC Animal Hospital onboards Dr. Prabhakaran Palanichamy as Senior Veterinary ExpertFebruary 6, 2024 | msn.comVertex's (VRTX) Q4 Earnings and Sales Surpass EstimatesFebruary 5, 2024 | finance.yahoo.comGlobal Downstream Processing Market to Surpass 83.47 Billion by 2030 Driven by Rising Demand for BiopharmaceuticalsJanuary 30, 2024 | msn.comVertex non-opioid painkiller shows positive results in critical late-stage trial on acute painDecember 18, 2023 | businesswire.comViridian Therapeutics Announces Positive Clinical Data in Healthy Volunteer Study and Selects VRDN-003 as Potential Best-in-Class Subcutaneous anti-IGF-1R Program with Extended ...December 18, 2023 | finance.yahoo.comPivotal Life Sciences Announces the Closing of $389M for Pivotal bioVenture Partners Fund IIDecember 12, 2023 | finance.yahoo.comGlobal Semiconductor Industry Outlook 2024December 12, 2023 | finance.yahoo.comNuclear Medicine Market Valuation to Soar at 11.5% by 2030, Global Revenue to Exceed US$11 Bn: Fairfield Market ResearchNovember 21, 2023 | markets.businessinsider.comPivotal Appoints Cyrus Sigari to its Board of DirectorsOctober 25, 2023 | uk.finance.yahoo.comGlobal Neuromuscular Disease Therapeutics Market to Surge by $6.51 Billion by 2027, Driven by Novel Approvals and Screening TestsOctober 25, 2023 | msn.comJenaValve Trilogy heart valve meets primary endpoints in pivotal trialOctober 24, 2023 | markets.businessinsider.comJenaValve Announces Late-Breaking Data from the ALIGN-AR Pivotal Trial Meeting Safety and Efficacy EndpointsSee More Headlines Receive PVTTF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pivotal Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today4/24/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolOTCMKTS:PVTTF CUSIPN/A CIKN/A Webwww.pivotaltherapeutics.us Phone(289) 597-7970FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable Beta-0.43 (Almost) Everything You Need To Know About The EV MarketClick the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise. Get This Free Report Key ExecutivesMs. Rachelle MacSweeneyCo-Founder, CEO, President & DirectorMr. George Jackowski (Age 73)Co-Founder, Chief Scientific Officer & Director Comp: $265.77kKey CompetitorsAbliva AB (publ)OTCMKTS:NEVPFAcusphereOTCMKTS:ACUSAddex TherapeuticsOTCMKTS:ADDXFAeolus PharmaceuticalsOTCMKTS:AOLSAffymaxOTCMKTS:AFFYView All Competitors PVTTF Stock Analysis - Frequently Asked Questions How have PVTTF shares performed in 2024? Pivotal Therapeutics' stock was trading at $0.0018 on January 1st, 2024. Since then, PVTTF shares have increased by 0.0% and is now trading at $0.0018. View the best growth stocks for 2024 here. How do I buy shares of Pivotal Therapeutics? Shares of PVTTF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:PVTTF) was last updated on 4/24/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressPentagon contract could send this $2 AI stock soaringBehind the MarketsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe #1 Crypto for 2024InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pivotal Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
